Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares | Latest News RSS feed

Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares - Latest News


BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

BioTime shareholders will receive one share of AgeX common stock for every 10 shares of BioTime common stock held BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on ... read more

BioTime updates timeline for distribution of AgeX shares to Biotime shareholders

BioTime (NYSEMKT:BTX) announces that its Board of Directors intends to set a new record date for the distribution of AgeX Therapeutics shares to BioTime shareholders. The ratio of one share of AgeX co... read more

BioTime Reports Second Quarter Results and Recent Corporate Accomplishments

BioTime announced the distribution ratio for the upcoming distribution of AgeX. BioTime shareholders will receive one share of AgeX common stock for ... one of its pluripotent cell lines to Goliver Th... read more

Looking for another news?


BioTime Closes $43.2 Million AgeX Share Sale Transaction With Juvenescence

--(BUSINESS WIRE)--Sep 4, 2018--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that ... s planned upcoming distribution of ... read more


BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its Board of Directors has set the distribution ratio for the distribu... read more

BioTime Closes $43.2 Million AgeX Share Sale Transaction With Juvenescence

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has closed ... to move forward with its planned distribution of Age... read more

BioTime Reports Third Quarter Results and Recent Corporate Accomplishments

OncoCyte announced positive results from the Analytical Validation Study of its liquid biopsy lung cancer diagnostic test, DetermaVU™. BioTime Board of Directors approved a distribution of some or all ... read more

BioTime announces record date for the distribution of AgeX Therapeutics shares

BioTime (BTX +2.8%) has set July 31 record date for the distribution of AgeX Therapeutics shares. The final distribution ratio will be determined by the BioTime Board. BioTime expects the distribution ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us